A review of 65 years of human adenovirus seroprevalence

Introduction: Human adenovirus (HAdV)-derived vectors have been used in numerous pre-clinical and clinical trials during the last 40 years. Current research in HAdV-based vaccines focuses on improving transgene immunogenicity and safety. Because pre-existing humoral immunity against HAdV types corre...

詳細記述

書誌詳細

出版年:	Expert Review of Vaccines
主要な著者:	Franck J. D. Mennechet, Océane Paris, Aline Raissa Ouoba, Sofia Salazar Arenas, Sodiomon B. Sirima, Guy R. Takoudjou Dzomo, Amidou Diarra, Isidore T Traore, Dramane Kania, Karsten Eichholz, Eric A. Weaver, Edouard Tuaillon, Eric J. Kremer
フォーマット:	論文
言語:	英語
出版事項:	Taylor & Francis Group 2019-06-01
主題:	adenovirus vaccination gene therapy immunology seroepidemiology
オンライン･アクセス:	http://dx.doi.org/10.1080/14760584.2019.1588113